Search Results - "Verslype, C"
-
1
Hepatocellular carcinoma: ESMO-ESDO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in Annals of oncology (01-10-2012)Get full text
Journal Article -
2
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in Annals of oncology (01-10-2018)Get full text
Journal Article -
3
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
Published in Annals of oncology (01-06-2021)Get full text
Journal Article -
4
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Published in Annals of oncology (01-05-2019)Get full text
Journal Article -
5
Cabozantinib in hepatocellular carcinoma: results of a phase 2 placebo-controlled randomized discontinuation study
Published in Annals of oncology (01-03-2017)“…Cabozantinib, an orally bioavailable inhibitor of tyrosine kinases including MET, AXL, and VEGF receptors, was assessed in patients with hepatocellular…”
Get full text
Journal Article -
6
Robotic versus laparoscopic repeat hepatectomy: A comparative single-center study of perioperative outcomes
Published in European journal of surgical oncology (01-01-2025)“…A repeat liver resection is considered a technically challenging procedure and therefor an open approach is frequently preferred. With the introduction of…”
Get full text
Journal Article -
7
Molecular classification of hepatocellular carcinoma anno 2011
Published in European journal of cancer (1990) (01-08-2011)“…Abstract Hepatocellular carcinoma has an increasing incidence and high mortality. Treatment options are limited if the disease is not diagnosed in its early…”
Get full text
Journal Article -
8
The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin
Published in Histopathology (01-08-2006)“…Aims: Cytokeratin (CK) 7 and CK19 expression, present in hepatic progenitor cells (HPCs) and in cholangiocytes but not in normal hepatocytes, has been…”
Get full text
Journal Article -
9
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
Published in Oncogene (23-11-2017)“…Human hepatocellular carcinomas (HCCs) expressing the biliary/hepatic progenitor cell marker keratin 19 (K19) have been linked with a poor prognosis and…”
Get full text
Journal Article -
10
Early features of acute-on-chronic alcoholic liver failure: a prospective cohort study
Published in Gut (01-11-2010)“…'Acute-on-chronic liver failure' (ACLF) is characterised in a more advanced stage by liver failure associated with multiple other end-organ failure. The global…”
Get more information
Journal Article -
11
Sorafenib: from literature to clinical practice
Published in Annals of oncology (01-04-2013)“…Sorafenib is considered the standard systemic therapy for hepatocellular carcinoma (HCC), in patients with well-preserved liver function (Child-Pugh A class)…”
Get full text
Journal Article -
12
Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
Published in Journal of clinical oncology (15-04-2004)“…To determine whether addition of the farnesyltransferase inhibitor tipifarnib (Zarnestra, R115777; Johnson and Johnson Pharmaceutical Research and Development,…”
Get full text
Journal Article -
13
Review article: blood platelet number and function in chronic liver disease and cirrhosis
Published in Alimentary pharmacology & therapeutics (01-06-2008)“…Summary Background The liver plays a central role in coagulation and fibrinolysis but is also closely intertwined with the function and number of blood…”
Get full text
Journal Article -
14
Comparison of diagnostic accuracy of (111)In-pentetreotide SPECT and (68)Ga-DOTATOC PET/CT: A lesion-by-lesion analysis in patients with metastatic neuroendocrine tumours
Published in European radiology (01-03-2016)“…To compare the diagnostic accuracy of (111)In-pentetreotide-scintigraphy with (68)Ga-DOTATOC-positron emission tomography (PET)/computed tomography (CT) in…”
Get full text
Journal Article -
15
Systematic review: the pathophysiology and management of polycystic liver disease
Published in Alimentary pharmacology & therapeutics (01-10-2011)“…Aliment Pharmacol Ther 2011; 34: 702–713 Summary Background Polycystic liver diseases (PCLD) represent a group of genetic disorders in which cysts occur…”
Get full text
Journal Article -
16
-
17
Transition from laparoscopic to robotic liver surgery: clinical outcomes, learning curve effect, and cost-effectiveness
Published in Journal of robotic surgery (01-02-2023)“…The reproducibility of the implementation of robotic liver surgery (RLS) is still debated. The aim of the present study is to evaluate short-term outcomes and…”
Get full text
Journal Article -
18
Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
Published in Annals of oncology (01-05-2019)Get full text
Journal Article -
19
New strategies and designs in pancreatic cancer research: consensus guidelines report from a European expert panel
Published in Annals of oncology (01-03-2012)“…Although the treatment of pancreatic ductal adenocarcinoma (PDAC) remains a huge challenge, it is entering a new era with the development of new strategies and…”
Get full text
Journal Article -
20
Combination of gemcitabine and cetuximab in patients with advanced cholangiocarcinoma: a phase II study of the Belgian Group of Digestive Oncology
Published in Annals of oncology (01-11-2013)“…Cholangiocarcinomas are uncommon tumours with a poor prognosis, that frequently present epidermal growth factor receptor overexpression. In a multi-centre…”
Get full text
Journal Article